OraSure suit, sales
This article was originally published in The Tan Sheet
Executive Summary
Additional expenses associated with Schering-Plough patent suit "will make it difficult to achieve full-year profitability in fiscal 2004," OraSure CEO Douglas Michels says Aug. 3. The Bethlehem, Penn.-based firm recently filed suit against Schering for infringement of several cryosurgical wart removal patents (1"The Tan Sheet" Aug. 2, 2004, p. 11). OraSure's total revenues increased 37% to $13.2 mil. in the second quarter (ended June 30) on the strength of Freeze Off and Histofreezer sales...